Can Hearing Aids Improve Memory and Executive Function?

Quick Answer

For decades, hearing loss was treated primarily as a communication disorder. The clinical goal was straightforward: improve access to speech so that patients could hear conversations, participate more fully in daily life, and remain connected with family and friends.

Those outcomes remain essential, but a rapidly expanding body of research suggests that the potential consequences of hearing loss extend well beyond communication. Hearing loss has been associated with greater listening effort, social withdrawal, changes in brain structure and function, cognitive decline, and an increased risk of dementia. Tinnitus and difficulty understanding speech in background noise have also emerged as potentially important indicators of auditory and neurological vulnerability.

These associations have led to an increasingly important question: when hearing loss is appropriately treated, can measurable cognitive performance improve?

Our research, presented at the 2025 Alzheimer’s Association International Conference and subsequently published in Alzheimer’s & Dementia, examined cognitive performance before and after adults with bilateral hearing loss began using prescription hearing aids. The findings showed measurable improvement in specific cognitive abilities following treatment, with gains in memory and executive function appearing early and remaining evident approximately one year later.

The results do not establish that hearing aids prevent Alzheimer’s disease or reverse dementia. They do, however, add to a growing body of evidence suggesting that restoring auditory access may influence how efficiently the brain performs certain cognitive tasks.

What This Article Covers

• Hearing Is a Brain Function
• Why Untreated Hearing Loss May Affect Cognitive Health
• Tinnitus and Speech-in-Noise Difficulty May Also Matter
• The Question Our Research Asked
• How Cognitive Performance Was Measured
• Memory Improved After Hearing Treatment
• Executive Function Also Improved
• Not Every Cognitive Domain Improved
• Why the Early Improvement Is Noteworthy
• Why the Gains May Have Stabilized
• Could Practice Effects Explain the Results?
• What the Study Can Tell Us
• What the Study Cannot Tell Us
• How These Findings Fit With Larger Hearing and Cognition Studies
• Hearing Treatment May Support Cognition Through Several Pathways
• Why Prescription Treatment Matters
• Why Earlier Treatment May Be Important
• Cognitive Screening in Hearing Healthcare
• What These Findings Mean for Patients
• The Importance of Maintaining Realistic Expectations
• The Clinical Significance of the Research
• The Bottom Line

Hearing Is a Brain Function

The ears collect and convert sound, but hearing ultimately occurs in the brain.

To follow a conversation, the auditory system must transmit a detailed neural representation of speech. The brain must then separate the speaker’s voice from competing sounds, identify phonemes and words, connect those words with meaning, retain information in working memory, and prepare an appropriate response.

When auditory input is clear, many of these processes occur rapidly and with little conscious effort. When hearing loss degrades the signal, the brain must compensate.

A listener may use facial expressions, sentence context, previous knowledge, visual information, and educated guessing to reconstruct portions of speech that were not heard accurately. This compensation can allow a person to remain functional, but it requires additional cognitive resources.

The brain has a limited amount of processing capacity available at any moment. When more attention and working memory are devoted to deciphering speech, fewer resources may remain available for understanding, learning, memory formation, decision-making, and other higher-order tasks.

This is commonly described as increased cognitive load or effortful listening.

The concept is not new. More than five decades ago, experimental research demonstrated that even relatively mild hearing difficulty could create apparent memory failures because participants had to use additional mental resources to perceive speech accurately. Our study examined whether reducing that auditory burden through prescription hearing treatment would be accompanied by measurable changes in cognitive performance.

Why Untreated Hearing Loss May Affect Cognitive Health

The relationship between hearing loss and cognition is unlikely to be explained by a single mechanism.

Increased cognitive load is one possibility. When the brain continually works harder to process degraded sound, attention and memory systems may remain under sustained demand.

Social withdrawal provides another possible pathway. People who repeatedly struggle in conversation may begin avoiding restaurants, meetings, family gatherings, and other socially or cognitively stimulating activities. Reduced participation can contribute to loneliness, depression, and diminished mental stimulation, all of which have independently been associated with poorer cognitive outcomes.

Auditory deprivation may also contribute to changes in the brain itself. Neuroimaging studies have associated hearing loss with accelerated volume loss in auditory and temporal regions, altered functional connectivity, and cross-modal cortical reorganization in which visual systems increasingly recruit areas that would ordinarily contribute to auditory processing.

These findings should not be interpreted to mean that hearing loss inevitably causes brain atrophy or dementia. They do suggest that the amount and quality of auditory information reaching the brain may influence how neural resources are organized over time.

Our poster also discussed evidence connecting hearing loss with reduced brain volume and cortical reorganization. The accompanying illustration contrasted a brain associated with normal hearing with one depicting the pattern of atrophy associated with hearing impairment, emphasizing that chronic auditory deprivation may have consequences beyond reduced audibility.

Tinnitus and Speech-in-Noise Difficulty May Also Matter

Hearing loss is not the only auditory condition associated with cognitive risk.

Difficulty understanding speech in background noise may emerge before a conventional hearing test reveals substantial threshold loss. Speech-in-noise performance depends on the integrity of the cochlea and auditory nerve, but it also requires attention, working memory, processing speed, inhibition, and executive control.

A large UK Biobank study involving more than 82,000 participants found that poor speech-in-noise performance was associated with an increased risk of incident dementia over approximately 11 years. That association does not prove that speech-in-noise difficulty causes dementia, but it suggests that impaired real-world listening may provide information about neural function that is not captured by a conventional audiogram alone.

Tinnitus has also been associated with cognitive and psychological symptoms and with increased risk of certain neurological disorders in population-based research. Tinnitus may reflect cochlear or neural dysfunction and can involve auditory, attentional, emotional, and limbic brain networks.

Neither tinnitus nor difficulty hearing in noise should be treated as proof that a patient is developing dementia. They should, however, be viewed as clinically meaningful symptoms that warrant proper evaluation rather than dismissal.

The Question Our Research Asked

The primary research question was simple: Does treating hearing loss with prescription hearing aids improve cognitive performance?

To explore that question, adults with bilateral hearing loss were evaluated before beginning prescription hearing-aid treatment and again after treatment had been established.

The conference poster describes a clinical cohort of 19 adults who were new hearing-aid users. Hearing loss was defined as bilateral pure-tone thresholds poorer than 25 dB HL between 2,000 and 8,000 Hz. Participants completed cognitive screening before treatment, approximately 60 days after beginning treatment, and again at approximately 12 months.

The subsequently published conference abstract describes a broader sample of 50 midlife adults evaluated at baseline, 30 days, and 12 months. It reports significant improvement in memory, executive function, and visuospatial memory at both post-treatment assessments.

The distinction between these two reports is important. The poster appears to present a defined subgroup or a particular stage of the analysis involving 19 new users and a 60-day follow-up, whereas the published abstract reports findings from a larger sample and a 30-day follow-up. The most conservative interpretation is that both presentations support early cognitive change following hearing treatment, while the specific domains reaching statistical significance depended on the sample and analysis being reported.

For the detailed discussion below, the individual domain findings are drawn primarily from the poster because it provides the underlying graphs, timing, sample description, and statistical annotations.

How Cognitive Performance Was Measured

Participants were assessed using Cognivue Thrive, an FDA-cleared computerized cognitive screening tool intended to help identify possible cognitive impairment.

The assessment does not diagnose Alzheimer’s disease, mild cognitive impairment, or another neurological condition. It is a screening instrument that evaluates performance across several cognitive domains and can indicate when additional investigation may be appropriate.

Cognivue Thrive uses visually presented, interactive tasks controlled through a handheld rotary device. This format is particularly relevant in hearing research because it reduces the risk that poor auditory access will directly interfere with the administration of the cognitive screening itself.

The five areas assessed in the poster were memory, executive function, visuospatial memory, reaction time, and processing speed.

Memory reflects the ability to encode, store, and retrieve information. Executive function includes higher-order abilities such as attention, inhibition, working memory, judgment, reasoning, and problem-solving. Visuospatial memory involves remembering and interpreting the location and relationship of objects in space. Reaction time measures how quickly a response begins after a stimulus appears, while processing speed reflects how rapidly information is interpreted and acted upon.

Evaluating several domains was important because cognition is not a single ability. Hearing treatment might influence some cognitive functions while leaving others unchanged.

Memory Improved After Hearing Treatment

The clearest finding involved memory.

Participants showed a statistically significant improvement in memory scores approximately 60 days after beginning prescription hearing-aid treatment. That improvement remained evident at the one-year follow-up.

The poster’s memory graph shows an increase from the pretreatment assessment to the first post-treatment assessment, followed by a generally stable score at one year. The difference between baseline and both post-treatment measurements reached statistical significance, while the difference between the 60-day and one-year scores did not.

This pattern suggests that the measurable improvement occurred relatively early and was then maintained, rather than continuing to increase throughout the year.

One possible explanation is that improving auditory access reduced the amount of effort required to process everyday sound, allowing cognitive resources to be allocated more efficiently. Another possibility is that better hearing increased conversation, engagement, confidence, and exposure to cognitively stimulating activities.

The study was not designed to determine which mechanism produced the improvement. It demonstrates a temporal association between hearing treatment and better memory performance, but it cannot establish that one specific neurophysiological pathway was responsible.

It is also important to recognize that the result reflects performance on a cognitive screening measure. The study did not demonstrate that hearing treatment changes the underlying pathology of Alzheimer’s disease or prevents future dementia.

Even with those limitations, the finding is clinically meaningful. Memory performance did not merely remain stable; it improved after treatment and the gain was still present approximately one year later.

Executive Function Also Improved

Executive function showed a similar pattern.

Participants demonstrated statistically significant improvement approximately 60 days after beginning treatment, and the improvement remained evident at the one-year assessment. As with memory, there was no significant additional increase between the first follow-up and the one-year evaluation.

Executive function is essential for navigating complex daily life. It supports planning, judgment, problem-solving, inhibition, attention, mental flexibility, and working memory.

These same abilities are heavily involved in effortful listening. Following a conversation in a noisy environment requires the listener to focus on one speaker, suppress competing sound, hold partial information in memory, use context to fill in missed words, and continually update the meaning of the conversation.

When auditory input becomes clearer, some of that cognitive burden may be reduced.

The improvement in executive-function scores is therefore consistent with the cognitive-load hypothesis, although it does not prove that reduced listening effort was the sole cause. Increased device use, greater social participation, familiarity with the cognitive assessment, and other factors may also have contributed.

Nevertheless, the finding supports the broader concept that hearing treatment may affect more than speech audibility.

Not Every Cognitive Domain Improved

A strong scientific interpretation requires equal attention to the findings that were not statistically significant.

In the 19-participant poster cohort, visuospatial memory did not change significantly at either the 60-day or one-year assessment. Reaction time and processing speed also showed no significant changes across the three measurement points.

These results are important for several reasons.

First, they argue against describing hearing aids as producing a universal improvement across every area of cognition. The observed effects were domain-specific.

Second, the findings suggest that memory and executive function may be more responsive to improved auditory access than reaction time or processing speed, at least over the period studied.

Third, the modest sample size may have limited the study’s ability to identify smaller effects. A lack of statistical significance does not necessarily prove that no change occurred; it means the study did not detect a sufficiently reliable change in those domains.

The larger published abstract reported significant improvement in visuospatial memory in addition to memory and executive function. This difference may reflect the larger sample, different follow-up timing, or other analytical distinctions between the abstract and poster.

Rather than treating the reports as contradictory, they should be understood as evidence that the exact pattern of cognitive change requires confirmation in larger, carefully controlled studies.

Why the Early Improvement Is Noteworthy

One of the most interesting features of the findings is how quickly improvement appeared.

In the poster cohort, measurable gains in memory and executive function were present by approximately 60 days. The published abstract describes improvement as early as 30 days.

That timeframe is too short to assume that hearing treatment reversed established neurodegenerative disease or restored lost brain tissue. A more plausible interpretation is that improved auditory access may have enhanced functional cognitive performance by reducing listening effort, improving the efficiency of information processing, increasing engagement, or allowing the brain to allocate resources differently.

The brain may function better when it is no longer required to devote as much effort to reconstructing degraded sound.

This distinction between functional performance and disease modification is essential. A patient can perform better on cognitive tasks without any claim that Alzheimer’s pathology has been eliminated or reversed.

The result is still valuable. Better functional memory and executive performance can influence communication, independence, treatment adherence, decision-making, and quality of life.

Why the Gains May Have Stabilized

Memory and executive-function scores improved by the first follow-up and then remained relatively stable through one year.

Several interpretations are possible.

The initial improvement may represent the greatest reduction in auditory-related cognitive burden, occurring once participants had consistent access to clearer sound. After that early gain, performance may have reached a plateau.

It is also possible that additional improvement would require more than amplification alone. Hearing aids improve auditory access, but cognitive health is influenced by physical activity, cardiovascular health, sleep, nutrition, social engagement, education, mental health, and many other factors.

Auditory rehabilitation or structured cognitive and communication training might produce further changes beyond those achieved through hearing technology alone.

The study did not test these possibilities, but the pattern reinforces an important clinical point: prescription hearing aids may be a foundation for treatment, not the entire treatment process.

Could Practice Effects Explain the Results?

Any study that repeats the same or similar cognitive assessment must consider practice effects.

Participants may perform better simply because they have become more familiar with the test, the instructions, or the response method.

The study design does not completely eliminate that possibility. There was no untreated control group completing the same assessments at the same intervals, so the amount of change attributable specifically to hearing treatment cannot be isolated with certainty.

However, the domain-specific pattern is noteworthy. If repeated exposure alone produced a broad improvement, one might expect consistent gains across memory, executive function, visuospatial memory, processing speed, and reaction time. In the poster cohort, significant improvement was concentrated in memory and executive function, while several other domains remained unchanged.

That does not rule out practice effects, but it suggests that simple test familiarity may not fully explain the findings.

Future studies should include larger samples, untreated or delayed-treatment comparison groups, alternative test forms where possible, and adjustment for age, education, health status, baseline cognition, hearing-loss severity, and hearing-aid adherence.

What the Study Can Tell Us

The study provides real-world clinical evidence that adults with bilateral hearing loss may show measurable improvement in specific cognitive domains after beginning prescription hearing-aid treatment.

The poster data demonstrate statistically significant gains in memory and executive function at the first follow-up, with those gains maintained approximately one year later. The larger published abstract also reports improvement in visuospatial memory.

The findings are consistent with the possibility that restoring auditory stimulation reduces cognitive load and supports more efficient neural processing.

They also reinforce the clinical value of identifying and treating hearing loss before years of communication difficulty, withdrawal, and auditory deprivation accumulate.

What the Study Cannot Tell Us

This study does not prove that prescription hearing aids prevent dementia.

It does not establish that hearing treatment reverses Alzheimer’s disease, eliminates neurodegeneration, or guarantees cognitive improvement for every patient.

The poster cohort was modest in size, lacked an untreated control group, and involved participants receiving care through a clinical audiology network rather than through a randomized controlled trial.

The study also did not directly measure brain volume, neural plasticity, cognitive load, social engagement, or Alzheimer’s biomarkers. The proposed mechanisms are biologically plausible and supported by related research, but they were not directly demonstrated in this project.

The results should therefore be described as an association between hearing treatment and improved cognitive-screening performance—not as definitive proof of dementia prevention.

Scientific caution, however, should not lead to clinical inaction. A treatment does not need to guarantee dementia prevention to be worthwhile. Improving hearing, reducing communication difficulty, supporting social connection, and potentially improving memory or executive performance are valuable outcomes on their own.

How These Findings Fit With Larger Hearing and Cognition Studies

The results align with a broader body of observational and intervention research examining hearing treatment and cognitive health.

Longitudinal studies have found that adults who use hearing aids may experience slower cognitive decline than adults with untreated hearing loss. Systematic reviews and meta-analyses have also reported associations between hearing-device use and reduced long-term cognitive decline or dementia risk.

The ACHIEVE randomized controlled trial provided particularly important evidence. Across the overall trial population, the hearing intervention did not significantly reduce cognitive decline over three years. However, among participants with greater baseline risk for cognitive decline, hearing intervention was associated with an approximately 48% slower rate of cognitive decline.

That finding does not mean hearing aids reduce cognitive decline by 48% in everyone. It suggests that the potential cognitive effects of hearing treatment may be greatest among adults who already possess additional risk factors.

Our study examined a different question and timeframe. Rather than measuring the rate of long-term decline across a large randomized population, it assessed whether cognitive-screening scores changed after hearing treatment in a real-world clinical cohort.

The results contribute to the same emerging theme: hearing treatment may influence cognitive outcomes, but the effect is unlikely to be identical in every person or every cognitive domain.

Hearing Treatment May Support Cognition Through Several Pathways

Improved cognitive performance after hearing treatment could result from several overlapping mechanisms.

Clearer auditory input may reduce the cognitive effort required to understand speech. This may allow attention and working memory to be used more efficiently.

Better hearing may also improve social participation. Conversations become less frustrating, and patients may be more willing to attend gatherings, return to hobbies, communicate with family members, and participate in cognitively stimulating activities.

Treatment may reduce anxiety associated with misunderstanding others and lessen the exhaustion that often follows prolonged listening.

Restored auditory stimulation may also influence neural plasticity by providing the auditory system with more consistent access to meaningful sound. Research has shown that the brain reorganizes in response to sensory deprivation and that some cortical changes may be modified after hearing treatment.

The current study did not determine which of these mechanisms was most important. The likely explanation is not one pathway but a combination of auditory, cognitive, emotional, social, and neural effects.

Why Prescription Treatment Matters

The study involved prescription hearing aids provided through clinical audiology care.

That distinction matters because effective hearing treatment requires more than obtaining a device.

The patient must receive an appropriate evaluation, and the technology must be selected according to the individual’s hearing loss, communication needs, anatomy, cognitive abilities, lifestyle, and goals. The devices must then be programmed, verified, validated, and adjusted over time.

Poorly fitted or inconsistently used hearing aids may not provide the auditory access needed to reduce listening effort meaningfully.

Treatment also includes counseling, communication strategies, family education, auditory rehabilitation, and follow-up. Patients must learn how to use the devices, adapt to renewed sound, manage challenging environments, and integrate treatment into daily life.

The potential cognitive benefit is therefore more accurately attributed to comprehensive hearing intervention than to the physical presence of hearing aids alone.

Why Earlier Treatment May Be Important

Many adults wait years between first noticing hearing difficulty and seeking treatment.

During that interval, the brain continues processing a degraded signal. Communication becomes increasingly effortful, and patients may gradually alter their behavior to avoid difficult listening situations.

The traditional approach has often been to wait until hearing loss becomes severe enough to create obvious disability. The emerging hearing-and-cognition literature challenges that model.

If auditory deprivation increases cognitive demand and contributes to maladaptive changes in neural processing, then earlier treatment may offer a greater opportunity to preserve function.

This does not mean every minor hearing complaint requires immediate amplification. It means that tinnitus, difficulty hearing in noise, listening fatigue, and measurable hearing loss deserve comprehensive investigation rather than automatic reassurance that the problem is “not bad enough yet.”

Earlier care provides more options and may prevent communication and participation problems from becoming deeply established.

Cognitive Screening in Hearing Healthcare

The study also demonstrates the potential value of incorporating cognitive screening into hearing healthcare.

Cognitive screening is not dementia diagnosis. It is a structured method of identifying possible concern and determining whether further evaluation may be appropriate.

Knowing that a patient has difficulty with memory, attention, executive function, or processing speed can also help the hearing professional tailor treatment. Instructions may need to be simplified, repeated, or provided in writing. A family member or caregiver may need to participate. Follow-up may need to be more frequent, and technology may need to be selected with ease of use in mind.

Longitudinal screening can help document whether performance changes over time, although screening results must always be interpreted in context.

The purpose is not to use hearing clinics as substitutes for neurology, psychology, or primary care. It is to recognize that hearing and cognition interact and that appropriate referral can be an important component of patient-centered care.

What These Findings Mean for Patients

Patients should not be told that hearing aids will prevent dementia.

They should be told that untreated hearing loss has been consistently associated with cognitive decline and that hearing treatment may support cognitive health, particularly in some higher-risk adults.

They should also understand that treating hearing loss provides immediate benefits regardless of its long-term effect on dementia risk.

Improved access to speech can reduce misunderstanding, increase confidence, support relationships, preserve independence, and make daily communication less exhausting.

The possibility that memory and executive performance may also improve gives patients another evidence-based reason to take hearing health seriously.

The goal is not fear. It is informed decision-making.

Patients deserve to know both the potential consequences of untreated hearing loss and the limitations of the available evidence.

The Importance of Maintaining Realistic Expectations

Not every patient will experience a measurable cognitive improvement after beginning hearing treatment.

Cognition is influenced by many factors, including age, education, cardiovascular health, diabetes, sleep, depression, medication burden, physical activity, neurological disease, and baseline cognitive reserve.

The severity and duration of hearing loss may also matter. A person treated soon after auditory decline begins may respond differently from someone who has lived with severe untreated hearing loss for decades.

Consistency of hearing-aid use, quality of fitting, engagement in rehabilitation, and social participation are also likely to influence outcomes. Hearing care should therefore be presented as one component of a broader healthy-aging strategy rather than a stand-alone solution to dementia.

The Clinical Significance of the Research

The most important message from this work is not that hearing aids are a cure for cognitive decline. It is that hearing treatment was followed by measurable improvement in memory and executive function, and those gains remained evident approximately one year later.

That finding challenges the assumption that hearing treatment affects only the ears. It supports a broader clinical model in which auditory health is recognized as part of cognitive, emotional, and functional health.

The study also demonstrates that cognitive outcomes can be measured in routine hearing-care settings. This creates opportunities for larger practice-based research projects examining who improves, which treatment variables matter, and whether cognitive changes are related to hearing-aid use, speech-in-noise improvement, social participation, tinnitus relief, or other clinical outcomes.

The Bottom Line

Hearing loss increases the amount of work the brain must perform to understand speech. Over time, that additional demand may affect memory, attention, executive function, social participation, and cognitive resilience.

Our research found that adults beginning prescription hearing-aid treatment demonstrated significant improvement in memory and executive-function performance within the first several weeks or months of treatment. In the poster cohort, those gains remained evident approximately one year later, while visuospatial memory, reaction time, and processing speed did not significantly change. The larger published abstract additionally reported improvement in visuospatial memory.

These results do not prove that hearing aids prevent dementia, and they should not be used to promise cognitive recovery to every patient. They do provide meaningful evidence that restoring auditory access may improve specific aspects of cognitive performance and that those improvements may persist.

Hearing treatment should not be delayed until communication becomes intolerable. It should be considered part of a comprehensive approach to preserving communication, social connection, independence, and brain health across the lifespan.

Reviewed & edited by Keith N. Darrow, Ph.D., CCC-A, FAAA — July 23, 2026.